Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus

Abstract

Letters3 July 2012Oral Pharmacologic Treatment of Type 2 Diabetes MellitusHelena W. Rodbard, MD and Paul S. Jellinger, MDHelena W. Rodbard, MDFrom Endocrine and Metabolic Consultants, Rockville, MD 20852; and University of Miami, The Center for Diabetes and Endocrine Care, Hollywood, FL 33021.Search for more papers by this author and Paul S. Jellinger, MDFrom Endocrine and Metabolic Consultants, Rockville, MD 20852; and University of Miami, The Center for Diabetes and Endocrine Care, Hollywood, FL 33021.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-157-1-201207030-00017 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The recently published American College of Physicians (ACP) clinical guidelines for management of patients with diabetes (1) fail to consider algorithms developed by the American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) (2) (for which we served as co-chairs of the task force that developed this algorithm), American Diabetes Association (ADA) (3), Canadian Diabetes Association (4), and Yale Diabetes Center (5). Although these algorithms were developed by specialists, they were specifically intended for use by internists and primary care physicians who treat most patients with type 2 diabetes. The AACE/ACE and ADA algorithms recommend target levels ...